Five innovators surrounded by sketches and prototypes in a London workshop, illustrating barriers to UK innovation funding.
Projects & Insights

270,000 Ideas Killed Every Year?

The hidden cost of Britain’s innovation funding gap

Britain celebrates innovation. We celebrate scientific discoveries, technological breakthroughs, successful entrepreneurs and billion-pound companies. We measure patents, research investment, startup valuations and the economic returns generated by innovation.

But there is one thing we rarely measure: the ideas that never get the chance to become innovations.

In 2023, the British Business Bank published a striking estimate in its Small Business Finance Markets 2022/23 report: financial barriers could be preventing up to 270,000 UK small and medium-sized enterprises (SMEs) from innovating every year.

Not 270,000 rejected grant applications. Not 270,000 failed businesses. And certainly not 270,000 inventions proven to be commercially viable.

The figure is an estimate of businesses potentially prevented from innovating because of the availability or cost of finance, derived from survey evidence covering 2018–2020.

But behind that estimate lies an uncomfortable question.

How many potentially valuable ideas never make it beyond someone’s imagination because their creator cannot afford to find out whether they work?

When having a good idea isn’t enough

Consider an experienced care worker who repeatedly encounters a problem that existing technologies fail to address. Or a small business owner who identifies a more efficient manufacturing process. Or an independent entrepreneur who develops a concept that could improve how patients understand their medical information.

These people might understand the problem better than anyone. They may even have a credible idea for solving it.

But turning that idea into a prototype requires money. Testing it requires expertise. Demonstrating its effectiveness requires resources, time and often access to specialist facilities.

And accessing funding to obtain those resources can involve another challenge: proving that the innovation is already sufficiently developed.

This is where the innovation funding paradox begins.

Some funding programmes require applicants to demonstrate a working prototype, reach a particular Technology Readiness Level (TRL), secure institutional partners or contribute a substantial proportion of the project costs themselves.

These requirements are not universal. Different programmes support different stages of innovation, and some offer full funding or advance payments.

Nevertheless, for entrepreneurs without considerable financial resources, the challenge can be circular:

You need funding to develop your innovation, but you need an adequately developed innovation to qualify for funding.

The result is not necessarily the rejection of an idea on scientific or commercial grounds.

Sometimes, the idea never reaches the point where anyone can properly evaluate it.

The evidence suggests the problem has not disappeared

The British Business Bank’s 270,000 estimate is historical, but more recent evidence suggests that financial barriers remain significant.

The Innovation State of the Nation 2026 report, published by the Innovation and Research Caucus, surveyed 2,037 UK businesses.

Among 706 surveyed businesses that had not reported product or service innovation during the preceding year:

  • 28% identified a lack of internal finance as a barrier.
  • 25% identified a lack of public funding.
  • 19% identified a lack of bank or equity finance.

These categories overlap, so they cannot be added together. Nor do they establish that finance was the only obstacle: uncertain demand, regulatory requirements and other business considerations were also reported.

Nevertheless, the figures demonstrate that insufficient finance continues to feature among the reasons businesses give for not innovating.

And financial barriers are not the only concern.

There is a difference between being capable of developing a valuable innovation and being capable of navigating a complex funding application.

A company with experienced grant writers, established research partnerships and available capital may be considerably better positioned to compete for funding than a small entrepreneur developing an equally interesting idea.

That does not mean the better-resourced company is undeserving. Nor does it mean public funding assessments are necessarily unfair.

It raises a more fundamental question:

Are we identifying the innovations with the greatest potential, or only those whose creators have the resources to enter the competition?

Britain already knows how valuable innovation can be

In October 2025, the Department for Science, Innovation and Technology published The Value of Public R&D.

Its conclusion was remarkable.

For every £1 invested in civil public research and development, the UK generates an estimated £8 in long-term net economic benefits.

The department also acknowledged that the wider social returns, including improvements in health, environmental protection, national security and quality of life, could be higher.

This is an estimate across the overall public R&D portfolio, not a guarantee that every project will generate an eightfold return.

But it illustrates something important: investment in research and innovation can create value far beyond the organisation receiving the money.

Successful innovations can generate employment, improve productivity, reduce public expenditure and address problems that existing services have struggled to solve.

And this raises another uncomfortable possibility.

If investment in innovation can generate substantial benefits, what is the potential cost of failing to invest in promising ideas at the stage when they most need support?

We cannot multiply 270,000 by an assumed financial return and declare that Britain has lost billions. There is no evidence to support such a calculation.

Many ideas would fail. Others might prove commercially unviable or offer only modest improvements.

But some might become valuable businesses, life-changing technologies or services that improve thousands of people’s lives.

The difficulty is that we may never know which ones.

The funding system faces a difficult balancing act

Public funding cannot, and should not, finance every idea.

Taxpayers deserve accountability. Funding agencies need evidence that projects are scientifically credible, technically feasible and capable of delivering meaningful outcomes.

Match funding can demonstrate commercial commitment. Technology readiness requirements can help ensure that funding reaches projects appropriate to a particular programme.

These are legitimate considerations.

But financial capacity should not be mistaken for innovative capacity.

An entrepreneur who cannot contribute £30,000 towards a development project does not necessarily have a weaker idea than someone who can.

Similarly, lacking an established research consortium does not mean the underlying problem is unimportant.

Encouragingly, there is evidence that public funding bodies recognise these barriers.

In its January 2026 response to Parliament’s inquiry into female entrepreneurship, the government acknowledged that funding requirements can disadvantage some businesses. It identified Innovate UK programmes that had introduced no-match-funding arrangements and partial upfront payments to improve accessibility.

This demonstrates that different funding structures are possible.

The challenge is ensuring that promising early-stage ideas have realistic opportunities to obtain initial evidence, without weakening the standards required for larger investments.

Small proof-of-concept awards, proportionate application processes, milestone-based financing and access to professional technical expertise could all play a role.

We do not need to eliminate risk from innovation. Risk is intrinsic to the process.

We need to distinguish between the risk that an idea might fail and the financial circumstances of the person proposing it.

And what happens when innovators look elsewhere?

There is another dimension to Britain’s innovation funding challenge.

What happens when entrepreneurs decide that developing their innovations in another country offers better opportunities?

The evidence suggests that this is more than a hypothetical concern.

The ScaleUp Institute’s Annual Review 2025 reported that 24% of surveyed UK scaleup businesses were considering relocating their headquarters abroad, with the European Union the most frequently preferred destination and the United States second.

A government-commissioned study of the UK artificial intelligence sector, published in October 2026, found that 43% of surveyed AI businesses considered it likely that insufficient scale-up funding could prompt them to relocate AI activities outside Britain.

These figures describe intentions and anticipated responses, not confirmed departures. The businesses surveyed are also different from the financially constrained SMEs underlying the British Business Bank’s historical estimate.

Furthermore, access to finance is not the only reason entrepreneurs consider relocating. Larger markets, taxation, infrastructure, access to talent and investor expectations all influence these decisions.

And international expansion is not necessarily a loss to Britain. A company may establish overseas operations while retaining research, employment and substantial economic activity in the UK.

Nevertheless, the evidence identifies a genuine concern: some businesses believe their future development may be better supported elsewhere.

For a country seeking to strengthen its position as a global centre for science, technology and entrepreneurship, that deserves attention.

The innovations we never see

Britain has universities producing world-class research, ambitious entrepreneurs, experienced professionals identifying everyday problems and businesses capable of developing new technologies.

It also has substantial innovation funding programmes and institutions that have successfully supported research, development and commercial growth.

Yet the question raised by the British Business Bank’s estimate remains.

What happens to the potential that lies outside the reach of conventional financing?

An innovation that fails after proper testing has at least been given an opportunity to demonstrate its value.

An innovation that is never developed because its creator cannot afford the first step leaves us with no such evidence.

We cannot know how many of those unrealised ideas would have succeeded.

But we should be equally cautious about assuming that none of them mattered.

Perhaps Britain’s innovation challenge is not simply about investing more money. Perhaps it is also about ensuring that opportunities to innovate are not determined too heavily by who already has money.

And if Britain recognises the extraordinary economic and social returns that innovation can generate, it should also ask whether it is doing enough to discover promising ideas before financial barriers make them disappear.

Because the real cost of inaccessible innovation funding may not appear in any annual balance sheet.

It may be found in the inventions never built, the companies never created, the treatments never developed and the problems that remain unsolved.

If Britain cannot give its innovators a realistic opportunity to develop their ideas, should it be surprised when some decide to take those ideas — and their potential future value — to the United States or Europe?


Sources

  1. British Business Bank — Small Business Finance Markets 2022/23, p. 40.
  2. Innovation and Research Caucus — Innovation State of the Nation Survey Report 2026, Table 4.4.
  3. Department for Science, Innovation and Technology — The Value of Public R&D, 2025.
  4. House of Commons — Female Entrepreneurship: Government Response, 2026.
  5. ScaleUp Institute — Annual Review 2025.
  6. Department for Science, Innovation and Technology — Artificial Intelligence Sector Study 2025.